Interrogation of a TCGA cohort of breast cancer patients identified a positive correlation between levels of FOXP3 and miR-200 members in breast cancer samples, and reduced expression of miR-200 in tumors from patients with metastatic disease. Here, FOXP3 is linked to breast cancer.